What is the National Allergy Strategy?

The National Allergy Strategy is a partnership between the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), working in consultation with key stakeholder organisations.

Allergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers. Currently affecting more than 4 million Australians, the rapid and continuing rise of allergic diseases is therefore a serious public health issue that requires action by all levels of government and the community. 

The National Allergy Strategy mission is to improve the health and quality of life of Australians with allergic diseases and minimise the burden of allergic diseases on individuals, their carers, healthcare services and the community.

Partners

Allergy & Anaphylaxis Australia (A&AA)
 

The leading national patient support organisation for allergy in Australia

A&AA was established in 1993 as a charitable, not for profit organisation, to improve awareness of allergy and anaphylaxis in the Australian community, by sharing current information, education, advocacy, research, guidance and support.

A&AA is proud to promote free membership and easy access to information and support. The organisation is supported by federal government funding, sponsorship, sale of a small number of resources and generous donations.

Their outreach extends to individuals, families, school, workplaces, health professionals, government, food industry and all Australians. 

The A&AA Medical Advisory Board comprises ASCIA members who are clinical immunology/allergy specialists from across Australia. A&AA is part of an international alliance of like-minded organisations and works closely with peak medical bodies, including ASCIA.

Australasian Society of Clinical Immunology and Allergy (ASCIA)

The peak medical body for clinical immunology and allergy in Australia and New Zealand

ASCIA was established in 1990 as a not for profit, peak professional medical organisation for allergy and clinical immunology in Australia and New Zealand.  ASCIA members include clinical immunology/allergy specialists, other medical practitioners, scientists and allied health professionals who work in the areas of allergy and immunology.  

The mission of ASCIA is to advance the science and practice of allergy and clinical immunology, by promoting the highest standard of medical practice, education and research, to improve the health and quality of life of people with allergic diseases, immunodeficiencies and other immune diseases. 

ASCIA is a member society of the World Allergy Organisation (WAO) and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI).  ASCIA is also affiliated with the Royal Australasian College of Physicians (RACP) as a specialty society. 

Content updated October 2021

Stay in touch with the National Allergy Strategy

A food allergy awareness project supported by

This project received funding from the Australian Government Department of Health.

Copyright © 2021 National Allergy Strategy